SeilerC. The human coronary collateral circulation. Eur J Clin Invest. 2010;40(5):465–476.
2.
WustmannKZbindenSWindeckerSMeierBSeilerC. Is there functional collateral flow during vascular occlusion in angiographically normal coronary arteries?Circulation. 2003;107(17):2213–2220.
3.
RentropKPCohenMBlankeHPhillipsRA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol. 1985;(3):587–592.
4.
SeilerCFleischMGarachemaniAMeierB. Coronary collateral quantitation in patients with coronary artery disease using intravascular flow velocity or pressure measurements. J Am Coll Cardiol. 1998;32(5):1272–1279.
5.
PiekJJvan LiebergenRAKochKTPetersRJDavidGK. Clinical, angiographic and hemodynamic predictors of recruitable collateral flow assessed during balloon angioplasty coronary occlusion. J Am Coll Cardiol. 1997;29(2):275–282.
6.
WernerGSFerrariMBetgeSGastmannORichartzBMFigullaHR. Collateral function in chronic total coronary occlusions is related to regional myocardial function and duration of occlusion. Circulation. 2001;104(23):2784–2790
7.
de MarchiSFGloeklerSMeierP. Determinants of preformed collateral vessels in the human heart without coronary artery disease. Cardiology. 2011;118(3):198–206.
8.
SchaperW. Collateral vessels reduce mortality. Eur Heart J. 2012;33(5):564–566.
9.
PippFBoehmSCaiWJ. Elevated fluid shear stress enhances postocclusive collateral artery growth and gene expression in the pig hind limb. Arterioscler Thromb Vasc Biol. 2004;24(9):1664–1668.
10.
CohenMRentropKP. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. Circulation. 1986;74(3):469–476.
11.
HabibGBHeibigJFormanSA. Influence of coronary collateral vessels on myocardial infarct size in humans. results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI investigators. Circulation. 1991;83(3):739–746.
12.
MeierPIndermuehleAPittB. Coronary collaterals and risk for restenosis after percutaneous coronary interventions: a meta-analysis. BMC Med. 2012;10:62.
13.
ChoiHKMountDBReginatoAM. Pathogenesis of gout. Ann Intern Med. 2005;143(7):499–516.
14.
AthyrosVGElisafMPapageorgiouAA. Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Am J Kidney Dis. 2004;43(4):589–599.
15.
DaskalopoulouSSMikhailidisDPAthyrosVGPapageorgiouAAElisafM. Fenofibrate and losartan. Ann Rheum Dis. 2004;63(4):469–470.
16.
AdamopoulosDVlassopoulosCSeitanidesBContoyiannisPVassilopoulosP. The relationship of sex steroids to uric acid levels in plasma and urine. Acta Endocrinol (Copenh). 1977;85(1):198–208.
17.
SuminoHIchikawaSKandaTNakamuraTSakamakiT.Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia. Lancet. 1999;21;354(9179):650.
18.
NathSDVorugantiVSArarNH. Genome scan for determinants of serum uric acid variability. J Am Soc Nephrol. 2007;18(12):3156–3163.
19.
BasagaHS. Biochemical aspects of free radicals. Biochem Cell Biol. 1990;68(7-8):989–998.
20.
JohnsonRJKangDHFeigD. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?Hypertension. 2003;41(6):1183–1190.
21.
BakerJFSchumacherHRKrishnanE. Serum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial. Angiology. 2007;58(4):450–457.
22.
GotsmanIKerenALotanCZwasDR. Changes in uric acid levels and allopurinol use in chronic heart failure: association with improved survival. J Card Fail. 2012;18(9):694–701.
23.
YooTWSungKCShinHS. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J. 2005;69(8):928–933.
24.
SundströmJSullivanLD'AgostinoRBLevyDKannelWBVasanRS. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension. 2005;45(1):28–33.
25.
KaragiannisAMikhailidisDPTziomalosK. Serum uric acid as an independent predictor of early death after acute stroke. Circ J. 2007;71(7):1120–1127.
26.
CulletonBFLarsonMGKannelWBLevyD. Serum uric acid and risk for cardiovascular disease and death: the Framingham heart study. Ann Intern Med. 1999;131(1):7–13.
27.
PalmerTMNordestgaardBGBennM. Association of plasma uric acid with ischaemic heart disease and blood pressure: Mendelian randomisation analysis of two large cohorts. BMJ. 2013;347:4262.
28.
UysalOKSahinDYDuranM. Association between uric acid and coronary collateral circulation in patients with stable coronary artery disease. Angiology. 2014;65(3):227–231.
29.
HsuPCSuHMLinTH. Association between coronary collaterals and serum uric acid level in Chinese population with acute coronary syndrome. Angiology. 2013;64(4):323–324.
30.
DuranMOrnekEMuratSN. High levels of serum uric acid impair development of coronary collaterals in patients with acute coronary syndrome. Angiology. 2012;63(6):472–475.
31.
KasapkaraHATopsakalRYarliogluesM. Effects of serum uric acid levels on coronary collateral circulation in patients with non-ST elevation acute coronary syndrome. Coron Artery Dis. 2012;23(7):421–425.
32.
HeapsCLParkerJL. Effects of exercise training on coronary collateralization and control of collateral resistance. J Appl Physiol. 2011;111(2):587–598.
33.
GloeklerSMeierPde MarchiSF. Coronary collateral growth by external counterpulsation: a randomised controlled trial. Heart. 2010;96(3):202–207.
